| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/18/2010 | WO2009157771A3 Antibody producing non-human mammals |
| 02/18/2010 | WO2009155324A3 Pigf-1 assay and kits and components thereof |
| 02/18/2010 | WO2009152417A3 Methods for improving viability and productivity in cell culture |
| 02/18/2010 | WO2009142888A3 Immortal unipotent porcine picm- 19h and picm- 19b stem cell lines |
| 02/18/2010 | WO2009137613A3 Methods and compositions for inducing brown adipogenesis |
| 02/18/2010 | WO2009124281A9 Novel antibodies against cancer target block tumor growth, angiogenesis and metastasis |
| 02/18/2010 | US20100043105 Polypeptides having acetylxylan esterase activity and polynucleotides encoding same |
| 02/18/2010 | US20100043100 Polynucleotides for regulation of high level tissue-preferred expression in crop plants |
| 02/18/2010 | US20100043099 Expression control elements from the lemnaceae family |
| 02/18/2010 | US20100043098 Plant raffinose saccharide biosynthetic enzymes |
| 02/18/2010 | US20100043097 Brassinosteroid Regulated Kinases (BRKs) That Mediate Brassinosteroid Signal Transduction and Uses Thereof |
| 02/18/2010 | US20100043084 Cotton varieties having a main stem load structure |
| 02/18/2010 | US20100043083 Insect chemosensory receptors and methods of use thereof |
| 02/18/2010 | US20100041743 Transgenic animal with enhanced immune response and method for the preparation thereof |
| 02/18/2010 | US20100041742 Riboswitches, methods for their use, and compositions for use with riboswitches |
| 02/18/2010 | US20100041741 Suppression of mitochondrial oxidative stress |
| 02/18/2010 | US20100041739 Transfection Reagent |
| 02/18/2010 | US20100041737 Gene Vector |
| 02/18/2010 | US20100041736 Isolated MCPIP and Methods of Use |
| 02/18/2010 | US20100041721 Selective androgen receptor modulators |
| 02/18/2010 | US20100041681 2-amino pyrimidine compounds as potent hsp-90 inhibitors |
| 02/18/2010 | US20100041646 Phenylene-Bis-Oxazolidine Derivatives and Their Use as Anticoagulants |
| 02/18/2010 | US20100041619 Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disorders |
| 02/18/2010 | US20100041610 Insecticidal toxin complex fusion protiens |
| 02/18/2010 | US20100041609 Interleukin-1 receptor antagonists, compositions, and methods of treatment |
| 02/18/2010 | US20100041606 Methods of Use of Eggshell Polypeptides |
| 02/18/2010 | US20100041597 Peptides targeted to protein kinase c isoforms and uses thereof |
| 02/18/2010 | US20100041596 Amelioration of Inflammatory Arthritis By Targeting the Pre-ligand Assembly Domain (Plad) of Tumor Necrosis Factor Receptors |
| 02/18/2010 | US20100041584 Gem difluorinated c-glycopeptides, their preparation and their use for the preservation of biological materials and/or in cryosugery |
| 02/18/2010 | US20100041150 Expansion of definitive endoderm cells |
| 02/18/2010 | US20100041149 Bioreactor and method for generating cartilage tissue constructs |
| 02/18/2010 | US20100041148 Process and support structure for the cultivation of living cells |
| 02/18/2010 | US20100041147 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 02/18/2010 | US20100041146 Three-dimensional cell culture carrier and method for cell culture using the same |
| 02/18/2010 | US20100041145 Tolerogenic dendritic cells, method for their production and uses therof |
| 02/18/2010 | US20100041144 Mammalian Cytokine; Related Reagents |
| 02/18/2010 | US20100041143 Holding petri dish, microinjection apparatus, and microinjection method |
| 02/18/2010 | US20100041142 Anti-apoptotic gene scc-s2 and diagnostic and therapeutic uses thereof |
| 02/18/2010 | US20100041141 Methods and compositions relating to improved lentiviral vectors and their applications |
| 02/18/2010 | US20100041140 Nucleic acid compounds for inhibiting bcl2 gene expression and uses thereof |
| 02/18/2010 | US20100041139 Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof |
| 02/18/2010 | US20100041138 IL-17 homologous polypeptides and therapeutic uses thereof |
| 02/18/2010 | US20100041137 Culture medium containing kinase inhibitors, and uses thereof |
| 02/18/2010 | US20100041136 Connective Tissue Growth Factor-2 |
| 02/18/2010 | US20100041135 Gastric Submucosal Tissue as a Novel Diagnostic Tool |
| 02/18/2010 | US20100041134 Self-assembling multicellular bodies and methods of producing a three-dimensional biological structure using the same |
| 02/18/2010 | US20100041133 Biological targeting compositions and methods of using the same |
| 02/18/2010 | US20100041132 Bioreactor System |
| 02/18/2010 | US20100041120 Botryoccocus braunii Triterpene Synthase Proteins and Nucleic Acid Molecules, and Methods for Their Use |
| 02/18/2010 | US20100041107 Method of reducing gene expression using modified codon usage |
| 02/18/2010 | US20100041103 Composition and method for enhancing cell growth and cell fusion |
| 02/18/2010 | US20100041102 Antagonists of pcsk9 |
| 02/18/2010 | US20100041074 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |
| 02/18/2010 | US20100041063 Anti-drug antibody assay |
| 02/18/2010 | US20100041028 Zinc finger binding domains for GNN |
| 02/18/2010 | US20100041025 Compositons, methods and kits for real-time nucleic acid analysis in live cells |
| 02/18/2010 | US20100041012 Rationally designed antibodies |
| 02/18/2010 | US20100041010 soaking the tissue in a cold stabilizing first solution, then in a polyether, salt, hydrogen peroxide and phosphate buffer second solution, in an alcohol and water to remove residues of the first solution and in a third solution of an antiinflammatory agent, an anticoagulant, alcohol and water |
| 02/18/2010 | US20100041009 Method for isolation of afterbirth derived cells |
| 02/18/2010 | US20100040754 Protein having sweetness |
| 02/18/2010 | US20100040675 Compositions and methods for promoting or inhibiting angiogenesis |
| 02/18/2010 | US20100040661 Materials and methods for cell growth |
| 02/18/2010 | US20100040660 Development of a tissue - engineered scaffold for nerve regeneration using a biocompatible and injectable hydrogel |
| 02/18/2010 | US20100040643 Flavivirus immunogens and methods of use |
| 02/18/2010 | US20100040641 Peptide vaccines for cancers expressing tumor-associated antigens |
| 02/18/2010 | US20100040637 Methods and Composition for Treating Diseases Targeting Prominin-1 (CD133) |
| 02/18/2010 | US20100040634 Methods and compositions for modulating hgf/met |
| 02/18/2010 | US20100040632 Composition |
| 02/18/2010 | US20100040621 Novel polpeptide and use thereof |
| 02/18/2010 | US20100040620 ANTI-CANCER ANTIBODIES AGAINST LEWISy AND LEWISb ANTIGENS |
| 02/18/2010 | US20100040612 Methods and compositions for reducing amyloid beta levels |
| 02/18/2010 | US20100040611 Antagonists of pcsk9 |
| 02/18/2010 | US20100040610 Antagonists of pcsk9 |
| 02/18/2010 | US20100040606 Recombinant polyclonal antibody for treatment of respiratory syncytial virus infections |
| 02/18/2010 | US20100040605 Antibody identifying an antigen-bound antibody and an antigen-unbound antibody, and method for preparing the same |
| 02/18/2010 | US20100040604 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 02/18/2010 | US20100040602 Antibodies against Human Cytimegalovirus (HCMV) |
| 02/18/2010 | US20100040597 Thrombin mutant |
| 02/18/2010 | US20100040590 Tumor-associated peptides binding to human leukocyte antigen (HLA) class II molecules |
| 02/18/2010 | US20100040588 Procurement, Isolation, and Cryopreservation of Endometrial/Menstrual Cells |
| 02/18/2010 | US20100040587 Cells for therapy of the heart, method of obtaining a cell preparation, and cell preparation |
| 02/18/2010 | US20100040585 Methods for isolating and using hematopoietic and embryonic stem cells of the peritoneal cavity |
| 02/18/2010 | US20100040582 Methods of selecting stem cells and uses thereof |
| 02/18/2010 | US20100040558 Green tea polyphenol alpha secretase enhancers and methods of use |
| 02/18/2010 | US20100040539 Vector System |
| 02/18/2010 | US20100040537 antibodies that are wild-type, chimeric, CDR grafted and humanized; disease or disorder in which prostaglandin E2 activity is detrimental, such as cancer, atuoimmune diseases, inflammatory diseases |
| 02/18/2010 | CA2734101A1 Composition for preventing or treating liver diseases containing plant stem cell lines derived from cambium of panax ginseng including wild ginseng or ginseng as active components |
| 02/18/2010 | CA2733985A1 Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compositions |
| 02/18/2010 | CA2733775A1 Agent for promoting neuronal differentiation and method therefor |
| 02/18/2010 | CA2733567A1 Improved vectors and yeast strains for protein production: ca2+ atpase overexpression |
| 02/18/2010 | CA2733399A1 Compositions and methods for the production of alpha-herpesviruses |
| 02/17/2010 | EP2154246A1 Viral vector and use thereof |
| 02/17/2010 | EP2154244A1 Cell culture method using amino acid-enriched medium |
| 02/17/2010 | EP2154243A1 Method for production of dendritic cell |
| 02/17/2010 | EP2154242A1 Method of inducing differentiation into myocardial cells using g-csf |
| 02/17/2010 | EP2154241A2 Cell culture well-plates having inverted colloidal crystal scaffolds |
| 02/17/2010 | EP2154240A1 PRF in cell and tissue culture |
| 02/17/2010 | EP2154154A1 G-protein-conjugated receptor having altered ligand affinity, and use thereof |
| 02/17/2010 | EP2154153A1 Mutant alpha-synuclein, and methods using same |
| 02/17/2010 | EP2153846A1 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immonostimulatory molecule |